MIP-1α (P=0.03) and MCP-1 (P=0.008) were shown to influence survival, with melanoma patients with the poorest survival rates showing high concentrations of MIP-1α and MCP-1 (Figure 4). This evidence concerns the gene CCL3 and melanoma.